ARCHIVES

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

NIH “RFA Game” Defeats Purpose Of OAM, Advisor Says

September 30, 1994

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

Clinton’s FY97 Budget Sees $12.4 Billion For NIH, $2.28B For NCI

March 22, 1996

NCI Unconventional Innovations Program releases Broad Agency Announcement.

October 24, 2003

Greatest Need Of Cancer Care Givers: “Will to Work Together,” ACCC President Anderson Says

August 15, 1986